XML 16 R4.htm IDEA: XBRL DOCUMENT v3.21.1
INTERIM CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)
 3 Months Ended 6 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Mar. 31, 2021
Mar. 31, 2020
Operating expenses        
General and administrative $ 2,233,745 $ 1,720,142 $ 3,704,401 $ 3,072,176
Research and development 6,720,841 6,053,047 14,646,360 12,401,715
Total operating expenses (8,954,586) (7,773,189) (18,350,761) (15,473,891)
Other income (expenses)        
Grant income 10,820 74,944 10,820 149,888
Research and development incentive income 960,879 717,328 2,230,195 1,660,543
Interest income, net 9,216 70,180 7,657 116,900
Foreign exchange gain (loss), net (154,563) (325,960) 178,071 (272,848)
Total other income, net 826,352 536,492 2,426,743 1,654,483
Net loss before provision for income taxes (8,128,234) (7,236,697) (15,924,018) (13,819,408)
Income tax expense, current (26,988) 0 (86,269) (9,214)
Net loss and comprehensive loss $ (8,155,222) $ (7,236,697) $ (16,010,287) $ (13,828,622)
Net Loss per share        
Basic and diluted $ (0.12) $ (0.12) $ (0.24) $ (0.24)
Weighted average number of shares outstanding        
Basic and diluted 68,594,867 58,353,954 66,421,380 56,544,037